Gujarat Inject (Kerala) Ltd.
₹11.14-₹0.08 (-0.71%)
Gujarat Inject (Kerala) Ltd.’s quoted price sits in the upper half of its reported 52-week range, 22.1% below the high.
BSE · TEJNAKSH.BO · INR
Stock price, earnings
Quote as of Oct 30, 2026, 06:42 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Tejnaksh Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 30.65% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Tejnaksh Healthcare Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Tejnaksh Healthcare Limited provides hospital and healthcare services in India. The company offers health care services through urology clinics, urology hospitals, and dental super specialty clinics; and operates multi-specialty hospitals, super-specialty hospitals, education institutes, pathology labs, super specialty training institutes, simulation institutes, and stone analysis labs. It also sells healthcare equipment, medical goods, and pharmaceuticals. In addition, the company is involved in the provision of inpatient and outpatient services. Tejnaksh Healthcare Limited was founded in 2003 and is headquartered in Dhule, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:21 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹11.14-₹0.08 (-0.71%)
Gujarat Inject (Kerala) Ltd.’s quoted price sits in the upper half of its reported 52-week range, 22.1% below the high.
₹49.18+₹0.19 (+0.39%)
Veerhealth Care Limited’s quoted price sits in the upper half of its reported 52-week range, 5.42% below the high.
₹43.45-₹0.56 (-1.27%)
Medinova Diagnostic Services Limited’s quoted price sits in the upper half of its reported 52-week range, 5.54% below the high.
₹143.00-₹6.95 (-4.63%)
Crestchem Limited’s quoted price sits in the upper half of its reported 52-week range, 22.7% below the high.
₹99.80-₹7.00 (-6.55%)
NG Industries Ltd.’s quoted price sits in the lower half of its reported 52-week range, 37.63% below the high.
₹41.42+₹0.01 (+0.02%)
Roopa Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 34.67% below the high.
₹41.35-₹1.60 (-3.73%)
Gujarat Terce Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 17.3% below the high.
₹45.00₹0.00 (0.0%)
KK Shah Hospitals Limited’s quoted price sits in the upper half of its reported 52-week range, 13.29% below the high.